TAM receptors are pleiotropic inhibitors of the innate immune response.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell

• Publication date

  2007-12-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CELL.2007.10.034PMID 18083102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The negative regulatory roles of suppressor of cytokine signaling proteins in myeloid signaling pathways

  2007influential reference
• The inflammation and coagulation cross-talk in patients with systemic lupus erythematosus

  2007cited by this paper
• Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells.

  2007influential reference
• Toll-like receptors in systemic autoimmune disease

  2006cited by this paper
• Type I Interferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors (DOI:10.1016/j.immuni.2006.08.009)

  2006influential reference
• Type I interferon in systemic lupus erythematosus and other autoimmune diseases.

  2006cited by this paper
• TLR signaling.

  2006influential reference
• Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6

  2006influential reference
• Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4

  2006cited by this paper
• Twist mediates suppression of inflammation by type I IFNs and Axl

  2006cited by this paper
• Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.

  2006cited by this paper
• Pathogen recognition and innate immunity.

  2006cited by this paper
• Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.

  2006cited by this paper
• Circuitry of nuclear factor kappaB signaling.

  2006cited by this paper
• Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases

  2006cited by this paper
• Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

  2006cited by this paper
• Toll-like receptor (TLR) response tolerance: a key physiological "damage limitation" effect and an important potential opportunity for therapy.

  2006cited by this paper
• Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors.

  2006cited by this paper
• TAM receptor function in the retinal pigment epithelium.

  2006cited by this paper
• Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis

  2006cited by this paper
• Type I Inteferon Gene Induction by the Interferon Regulatory Factor Family of Transcription Factors

  2006cited by this paper
• Orphanet Journal of Rare Diseases BioMed Central Review

  2006cited by this paper
• CD14 is required for MyD88-independent LPS signaling

  2005cited by this paper
• Negative regulation of cytokine signaling and immune responses by SOCS proteins

  2005influential reference
• Negative regulation of Toll-like receptor-mediated immune responses

  2005influential reference
• B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels

  2005cited by this paper
• Negative regulation of Toll-like-receptor signaling by IRF-4.

  2005cited by this paper
• A promiscuous liaison between IL‐15 receptor and Axl receptor tyrosine kinase in cell death control

  2005cited by this paper
• The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

  2004cited by this paper
• Toll-like receptor control of the adaptive immune responses

  2004cited by this paper
• Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity.

  2003influential reference
• Macrophage regulation by Tyro 3 family receptors.

  2003cited by this paper
• Signalling: STATs: transcriptional control and biological impact

  2002cited by this paper
• MAP kinases in the immune response.

  2002cited by this paper
• Homeostatic Regulation of the Immune System by Receptor Tyrosine Kinases of the Tyro 3 Family

  2001cited by this paper
• Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis

  2001cited by this paper
• Phagocytosis and clearance of apoptotic cells is mediated by MER

  2001cited by this paper
• Tyro-3 family receptors are essential regulators of mammalian spermatogenesis

  1999cited by this paper
• A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock.

  1999cited by this paper
• Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity.

  1997cited by this paper
• Unique signal transduction of Eyk: constitutive stimulation of the JAK‐STAT pathway by an oncogenic receptor‐type tyrosine kinase.

  1996influential reference
• The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.

  1995cited by this paper
• Functional role of type I and type II interferons in antiviral defense.

  1994cited by this paper
• Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase.

  1994cited by this paper
• An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system.

  1991cited by this paper
• Systemic lupus erythematosus.

  1977cited by this paper

• MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9+ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancer

  2026cites this paper
• Zika virus entry inhibitors.

  2026cites this paper
• MerTK-triggered TGFβ1 autocrine signal regulates microglial response to neurodegeneration.

  2026cites this paper
• Tetrahedral Framework Nucleic Acid Relieves Sepsis‐Induced Intestinal Injury by Regulating M2 Macrophages

  2025cites this paper
• Dendritic cell maturation in cancer

  2025cites this paper
• From pathogenesis to therapeutic targeting: new insight into TAM receptors in rheumatoid arthritis

  2025cites this paper
• PROS1/AXL signaling protects mice from lethal influenza infection by inducing M2 macrophage polarization.

  2025cites this paper
• Recent advances in TAM mechanisms in lung diseases

  2025cites this paper
• The Interplay Between Innate Immunity and Nonimmune Cells in Lung Damage, Inflammation, and Repair.

  2025cites this paper
• Establishing Tyro3, Axl, and Mertk Chinese hamster ovary (CHO) reporter cell lines for cancer immunology and therapeutic applications.

  2025cites this paper
• AXL and MERTK facilitate tissue repair in severe acute pancreatitis via a CCR5-dependent neutrophil and macrophage crosstalk

  2025cites this paper
• Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emerges.

  2025cites this paper
• AXL signaling in cancer: from molecular insights to targeted therapies

  2025cites this paper
• Machine learning and bioinformatics framework integration reveal potential characteristic genes related to immune cell infiltration in post-traumatic stress disorder

  2025cites this paper
• AXL in cardiovascular diseases: Pathophysiological insights and clinical perspectives.

  2025cites this paper
• At the intersection of immunology and oncology: TAM receptors in the regulation of immune responses and tumorigenesis-related processes

  2025cites this paper
• Prospects of current AXL-targeting therapies in early phase cancer trials

  2025cites this paper
• Genetic and Epigenetic Interconnections Between Atopic Dermatitis, Allergic Rhinitis, and Rhinitis with Nasal Polyps

  2025cites this paper
• Tyro3 deletion is protective in experimental autoimmune encephalomyelitis

  2025cites this paper
• Navigating TAM receptor dynamics in tumour immunotherapy

  2025cites this paper
• Efferocytosis in tissue engineering: A comprehensive review of emerging therapeutic strategies for enhanced tissue repair and regeneration

  2025cites this paper
• Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?

  2025cites this paper
• Inhibition of ADORA3 accelerates hematoma resolution and neurological recovery after ICH.

  2025cites this paper
• Mesenchymal stem cell–derived exosome delivery of let-7a-5p enhances macrophage efferocytosis via Arid3a/Mertk axis in acute-on-chronic liver failure

  2025cites this paper
• Immunomodulatory effect of efferocytosis at the maternal–fetal interface

  2025cites this paper
• Cholesterol mobilization regulates dendritic cell maturation and the immunogenic response to cancer

  2025cites this paper
• Efferocytosis: The Janus‐Faced Gatekeeper of Aging and Tumor Fate

  2025cites this paper
• AXL promotes malignant phenotypes in tumor cells and might be a potential antitumor target of natural products

  2025cites this paper
• Attenuating α-synuclein pathology in mice with in situ engineered astrocytes

  2025cites this paper
• Fucoidan Alleviates Chemotherapy-Induced Peripheral Neuropathy via Activating the Gas6/MerTK Signaling Pathway to Reduce Neuroinflammation.

  2025cites this paper
• Vitamin K supports TGF-β1 depended in vitro human Langerhans cell differentiation and function via Axl

  2025influential citation
• Paeoniflorin alleviated STZ-induced diabetic retinopathy via regulation of the PDI/ADAM17/MerTK pathway.

  2025cites this paper
• Viral apoptotic mimicry and the role of phosphatidylserine receptors

  2025cites this paper
• A single nucleotide polymorphism in the MerTK gene is associated with increased radiological disease activity in patients with multiple sclerosis on natalizumab therapy.

  2025cites this paper
• Axl inhibitor-mediated reprogramming of the myeloid compartment of the in vitro tumor microenvironment is influenced by prior targeted therapy treatment

  2025cites this paper
• Genetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS‐CoV‐2 Infection With and Without Diabetes

  2025cites this paper
• Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?

  2025cites this paper
• Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial

  2025cites this paper
• Genetic susceptibility to cerebral palsy involves complement system-mediated neuronal development and plasticity pathway

  2025cites this paper
• Infectious and Immunological Links Between Periodontitis and COVID-19: A Review

  2025cites this paper
• AXL Tyrosine Kinases: A Growing Isoform Family that Promotes Cancer Pathogenesis.

  2025cites this paper
• Corticosterone effects induced by stress and immunity and inflammation: mechanisms of communication

  2025cites this paper
• MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma

  2025influential citation
• Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patients

  2025cites this paper
• Inhibition of Axl attenuates acute kidney injury by alleviating inflammation via SOCS3 downregulation in tubular epithelial cells

  2025cites this paper
• A gut-selective Axl Inhibitor Attenuates Intestinal Fibrosis in myofibroblast cell models and the Mouse S. Typhimurium Model in vivo

  2025cites this paper
• Plasma extracellular vesicle surface-located GAS6/PROS1 and CD39/CD73 attenuate inflammation.

  2025cites this paper
• Efferocytosis and Its Role in Rheumatic Diseases

  2025cites this paper
• Exploratory study of serum protein biomarkers for sudden cardiac arrest using protein extension assay: A case-control study

  2025cites this paper
• Gas6 induces AIM to suppress acute lung injury in mice by inhibiting NLRP3 inflammasome activation and inducing autophagy

  2025cites this paper
• Enhancing Tyro3 signalling ameliorates IL-1β production through STAT1 in Alzheimer's disease models.

  2025cites this paper
• Immune Dysfunction and Infection Risk in Advanced Liver Disease.

  2025cites this paper
• Protein S as a therapeutic target.

  2025cites this paper
• TAM pathway proteins as novel salivary biomarkers for periodontitis.

  2025cites this paper
• Functions of TAM Receptors and Ligands Protein S and Gas6 in Atherosclerosis and Cardiovascular Disease

  2024cites this paper
• The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia.

  2024cites this paper
• Ozone promotes macrophage efferocytosis and alleviates neuropathic pain by activating the AMPK/Gas6-MerTK/SOCS3 signaling pathway

  2024cites this paper
• Contact Lens Wear Alters Transcriptional Responses to Pseudomonas aeruginosa in Both the Corneal Epithelium and the Bacteria

  2024cites this paper
• Profound deficiencies in mature blood and bone marrow progenitor dendritic cells in Chronic Lymphocyticcytic Leukemia patients

  2024cites this paper
• MERTK inhibition selectively activates a DC – T-cell axis to provide anti-leukemia immunity

  2024cites this paper
• MerTK Signaling in Human Primary T cells Modulates Memory Potential and Improves Recall response.

  2024cites this paper
• Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages

  2024cites this paper
• Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain.

  2024cites this paper
• AXL: A novel therapeutic target in IBD.

  2024cites this paper
• Chromosomal instability as an architect of the cancer stemness landscape

  2024cites this paper
• Phytochemical-mediated efferocytosis and autophagy in inflammation control

  2024cites this paper
• MERTK Inhibition as a Targeted Novel Cancer Therapy

  2024cites this paper
• Efferocytosis: Unveiling its potential in autoimmune disease and treatment strategies.

  2024cites this paper
• A Mouse Model of Sporadic Alzheimer’s Disease with Elements of Major Depression

  2024cites this paper
• Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment

  2024cites this paper
• Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements

  2024cites this paper
• The role of plasmacytoid dendritic cells (pDCs) in immunity during viral infections and beyond

  2024cites this paper
• Could Gas6/TAM Axis Provide Valuable Insights into the Pathogenesis of Systemic Sclerosis?

  2024cites this paper
• In the Eyes of the Beholder—New Mertk Knockout Mouse and Re-Evaluation of Phagocytosis versus Anti-Inflammatory Functions of MERTK

  2024cites this paper
• Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH

  2024cites this paper
• The effect of macrophages and their exosomes in ischemic heart disease

  2024cites this paper
• MerTK-dependent efferocytosis by monocytic-MDSCs mediates resolution of ischemia/reperfusion injury after lung transplant

  2024cites this paper
• Efferocytosis in dendritic cells: an overlooked immunoregulatory process

  2024cites this paper
• Role of TAM Receptors in Antimalarial Humoral Immune Response

  2024cites this paper
• Duodenal mucosa of untreated celiac disease patients has altered expression of the GAS6 and PROS1 and the negative regulator tyrosine kinase TAM receptors subfamily.

  2024cites this paper
• Regulation of Mertk Surface Expression via ADAM17 and γ-Secretase Proteolytic Processing

  2024cites this paper
• Gegen Qinlian Decoction Modulates Atherosclerosis and Lipid Metabolism Through Cellular Interplay and Signaling Pathways.

  2024cites this paper
• The TAM Subfamily of Receptor Tyrosine Kinases: The Early Years

  2024cites this paper
• Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer

  2024cites this paper
• Expression levels of tam receptors and ligands in the testes of rats exposed to short and middle‐term 2100 MHz radiofrequency radiation

  2024cites this paper
• GAS6/TAM Axis as Therapeutic Target in Liver Diseases

  2024influential citation
• Tyro3 promotes the maturation of glutamatergic synapses

  2024cites this paper
• Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome.

  2024cites this paper
• MERTK and Fibrosis: A New Target for Therapy

  2024cites this paper
• GAS6 and AXL promote insulin resistance by rewiring insulin signaling and increasing insulin receptor trafficking to endosomes

  2024cites this paper
• AXL inhibition suppresses early allograft monocyte-to-macrophage differentiation and prolongs allograft survival

  2024cites this paper
• From MASH to HCC: the role of Gas6/TAM receptors

  2024cites this paper
• Potential roles for efferocytosis in glioblastoma immune evasion

  2024cites this paper
• Vitamin K-dependent carboxylation in β-cells and diabetes.

  2024cites this paper
• Lupus Nephritis Biomarkers: A Critical Review

  2024cites this paper
• DNA hypomethylation ameliorates erosive inflammatory arthritis by modulating interferon regulatory factor-8

  2024cites this paper
• AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

  2024cites this paper
• CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus.

  2024cites this paper
• Immune checkpoints targeting dendritic cells for antibody-based modulation in cancer.

  2024cites this paper
• Differential regulation of lung homeostasis and silicosis by the TAM receptors MerTk and Axl

  2024influential citation